Great post Reilly. In furtherance to your point regarding the sale of derma, those funds could also be used for GMP facility in Malta. It may have been mentioned and I just looked past it on one of these posts, but the sale of derma would be massive. I could be wrong but I believe that if they sell the derma division then there will be no need to address the VC deal which so many people are hung up on. In my opinion, good riddance. Therefore everyone can go back to focusing on what really matters, the pharma and botanic divisions.
MXC Price at posting:
7.2¢ Sentiment: Buy Disclosure: Held
